Literature DB >> 7614940

Workshop on perinatal exposure to dioxin-like compounds. V. Immunologic effects.

L S Birnbaum1.   

Abstract

The immune system comprises a highly integrated network of multiple tissues and cell types with complicated interactions and effects. It is modulated by the endocrine and nervous systems and there is growing realization of its multifunctionality. The session focusing on immunologic effects of dioxin and related compounds following prenatal exposure involved a review of the immunotoxic effects that have been reported for polyhalogenated aromatic hydrocarbons (PHAHs), a discussion of species differences in responses, and development of the immune system, and data from two ongoing epidemiological studies comparing the immune status of children exposed to higher-than-average concentrations of PHAHs both prenatally and lactationally.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7614940      PMCID: PMC1518849          DOI: 10.1289/ehp.95103s2157

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  22 in total

Review 1.  Molecular and cellular events of T cell development.

Authors:  B J Fowlkes; D M Pardoll
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

2.  Lymphocyte stem cell alterations following perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  J S Fine; T A Gasiewicz; A E Silverstone
Journal:  Mol Pharmacol       Date:  1989-01       Impact factor: 4.436

3.  Relationship between Ah receptor-mediated polychlorinated biphenyl (PCB)-induced humoral immunosuppression and thymic atrophy.

Authors:  J B Silkworth; L Antrim
Journal:  J Pharmacol Exp Ther       Date:  1985-12       Impact factor: 4.030

4.  Humoral immunotoxicity of polychlorinated diphenyl ethers, phenoxyphenols, dioxins and furans present as contaminants of technical grade pentachlorophenol.

Authors:  N I Kerkvliet; J A Brauner; J P Matlock
Journal:  Toxicology       Date:  1985-09       Impact factor: 4.221

5.  The effect of perinatal exposure to tetrachlorodibenzo-p-dioxin on the immune response of young mice.

Authors:  P T Thomas; R D Hinsdill
Journal:  Drug Chem Toxicol       Date:  1979       Impact factor: 3.356

6.  Immunosuppressive effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin in strains of mice with different susceptibility to induction of aryl hydrocarbon hydroxylase.

Authors:  A Vecchi; M Sironi; M A Canegrati; M Recchia; S Garattini
Journal:  Toxicol Appl Pharmacol       Date:  1983-05       Impact factor: 4.219

7.  Effect of acute exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin on humoral antibody production in mice.

Authors:  A Vecchi; A Mantovani; M Sironi; W Luini; M Cairo; S Garattini
Journal:  Chem Biol Interact       Date:  1980-06       Impact factor: 5.192

8.  Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on pulmonary influenza virus titer and natural killer (NK) activity in rats.

Authors:  Y G Yang; H Lebrec; G R Burleson
Journal:  Fundam Appl Toxicol       Date:  1994-07

9.  Examination of bone marrow, immunologic parameters and host susceptibility following pre- and postnatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).

Authors:  M I Luster; G A Boorman; J H Dean; M W Harris; R W Luebke; M L Padarathsingh; J A Moore
Journal:  Int J Immunopharmacol       Date:  1980

10.  Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the immune system of laboratory animals.

Authors:  J G Vos; J A Moore; J G Zinkl
Journal:  Environ Health Perspect       Date:  1973-09       Impact factor: 9.031

View more
  2 in total

1.  Response to the ACPA's critique.

Authors:  R Repetto; S Baliga
Journal:  Environ Health Perspect       Date:  1998-02       Impact factor: 9.031

2.  Immunologic biomarkers in relation to exposure markers of PCBs and dioxins in Flemish adolescents (Belgium).

Authors:  Rosette L Van Den Heuvel; Gudrun Koppen; Jan A Staessen; Elly Den Hond; Geert Verheyen; Tim S Nawrot; Harry A Roels; Robert Vlietinck; Greet E R Schoeters
Journal:  Environ Health Perspect       Date:  2002-06       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.